Here are the DEF 14A proxy statements from Assembly Biosciences, Inc (ASMB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ASMB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASMB filings page.
Assembly Biosciences is asking stockholders to approve five key items at its 2026 annual meeting. The virtual-only meeting is scheduled for June 4, 2026 at 8:00 a.m. PDT. Holders of 15,892,608 shares of common stock as of April 10, 2026 may vote.
Stockholders will vote on electing nine directors, an advisory “say on pay” for named executive officers, and ratifying Ernst & Young LLP as auditor for 2026. They are also asked to approve increasing the 2018 Stock Incentive Plan share reserve by 1,200,000 shares and raising the Employee Stock Purchase Plan reserve to 515,000 shares. The Board recommends voting “FOR” all proposals and highlights a mainly independent Board, annual director elections, proxy access and the absence of a poison pill.